Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIIB021 + Exemestane in HR+ Advanced Metastatic Breast Cancer
NCT01004081Phase 2Completed
- Sponsor
- Biogen
- Start
- Nov 2009
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of biib021 in breast cancer, sponsored by Biogen. Started Nov 2009; status: completed.
02
Drugs
biib021
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01004081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01004081.